Detail akcie Abattis Bioceutic online

Business Summary: Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2019, AbattisBioceuticals Corp revenues increased from C$8K to C$357K.Net loss decreased 96% to C$3M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Lower net loss reflectsGain (transaction costs) on asset acquis decrease fromC$28.2M (expense) to C$337K (income), Transaction costs forbusiness combinati decrease from C$11.4M (expense) to C$0K.